- Certificate of completion - Free
- Tutor is available to students
Validation of test methods is a critical requirement for the drug development process. Bioassays are used to support biologics in the drug development process and in post-market analytical support.
Unlike analytical test methods for small molecules, bioassays have unique requirements due to the variable nature of some critical components. Although some variability may be inherent, careful attention to setting appropriate limits and to robust qualification of critical components enhances the likelihood of success during validation.
Regulatory agencies expect pharmaceutical companies and biopharmaceutical companies to use validated methods for late phase work. The methods are used to test large molecule drug substance or drug product for identity, purity, and potency. Poorly developed and inadequately validated methods often have high failure rates when in production. Data submitted from poorly developed/validated methods is subject to additional scrutiny due to the excessively high failure rate that lowers confidence in the data that is produced.
Cell-based methods may be difficult to validate due to a lack of extensive testing during the development phase. Method validation requires careful design of the method during development and seamless implementation to meet regulatory agency expectations for the quality of assay methods used in testing of biopharmaceutical or pharmaceutical compounds.
Cell-based methods have additional complexities that may contribute to variability. With appropriate controls in place in the method variability can be minimized leading to successful validation and sample analysis using the cell-based method.
Digital certificate - Included
Why you should Attend:
Bioassays, especially cell-based methods are a necessary component of assays providing data supporting large molecule therapeutics. Typically, these methods are required to establish potency, a critical quality attribute, in either release or stability assays. The live cell quality of these assays may introduce a layer of uncertainty regarding the ability to build a method that meets requirements for ruggedness.
Cells that express the receptor responsible for the mechanism of action may be a transfected clonal line or may be a cell expressing the native protein. The growth characteristics of the cell that promote expression levels with good signal-to-background in the method are an important quality to address as development of the assay begins.
A key question may be how much prework to perform to guide development of the assay. Live cells are not as simple to control as individual reagents in a method. Live cells respond to components in media, environmental factors, and seeding densities in a manner that may have an impact on growth characteristics, receptor expression, and signals in cell-based methods.
These issues should be assessed fully and examined in early development work to direct the lab toward the parameters likely to produce an assay with a low rate of failure. This complexity often leads to problems when factors that contribute to ruggedness in cell-based methods are not assessed and addressed during the development phase. Successful validation is achievable with careful consideration of the cells as the primary critical reagent.
Control of the assay starts with control of the cells. While sufficient time is needed to perform development using design of experiments, moving from development to validation should be based on the quality of the data observed in the assay and not inordinately pushed forward.
Areas Covered in the Session:
Currently there are no Q&As for this course. Be the first to ask a question.
Currently there are no reviews for this course. Be the first to leave a review.
This course is advertised on reed.co.uk by the Course Provider, whose terms and conditions apply. Purchases are made directly from the Course Provider, and as such, content and materials are supplied by the Course Provider directly. Reed is acting as agent and not reseller in relation to this course. Reed's only responsibility is to facilitate your payment for the course. It is your responsibility to review and agree to the Course Provider's terms and conditions and satisfy yourself as to the suitability of the course you intend to purchase. Reed will not have any responsibility for the content of the course and/or associated materials.
Interest free credit agreements provided by Zopa Bank Limited trading as DivideBuy are not regulated by the Financial Conduct Authority and do not fall under the jurisdiction of the Financial Ombudsman Service. Zopa Bank Limited trading as DivideBuy is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, and entered on the Financial Services Register (800542). Zopa Bank Limited (10627575) is incorporated in England & Wales and has its registered office at: 1st Floor, Cottons Centre, Tooley Street, London, SE1 2QG. VAT Number 281765280. DivideBuy's trading address is First Floor, Brunswick Court, Brunswick Street, Newcastle-under-Lyme, ST5 1HH. © Zopa Bank Limited 2024. All rights reserved.